TCL Archive President’s FY 1991 Budget Provides NCI 3.9% Increase, But Grant Budgets To Be Cut 20% February 2, 1990
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006